Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.45
-0.70 (-2.78%)
Oct 20, 2025, 1:52 PM CST
-2.78%
Market Cap1.82B
Revenue (ttm)563.09M
Net Income (ttm)-178.49M
Shares Out72.45M
EPS (ttm)-2.46
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume382,767
Average Volume321,655
Open24.70
Previous Close25.15
Day's Range24.20 - 25.35
52-Week Range14.30 - 29.60
Beta0.23
RSI40.78
Earnings DateNov 13, 2025

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; reproductive health and cancer testing services; and contract development and manufacturing services. Genomics BioSci & Tech. Co.,Ltd. was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2024, Genomics BioSci & Tech.'s revenue was 482.75 million, an increase of 21.86% compared to the previous year's 396.14 million. Losses were -223.10 million, 32.7% more than in 2023.

Financial Statements

News

There is no news available yet.